SEC Form 4 · accession 0001179110-15-011056

Teladoc Health, Inc. · TDOC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Sales Officer

Period of report

Jul 7, 2015

Accepted (ET)

Jul 9, 2015 · 1:55 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001477449

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jul 7, 2015	C	1,315	—	A	1,315	D
Common Stock^F2	Jul 7, 2015	C	725	—	A	725	D
Common Stock^F3	Jul 7, 2015	C	2,154	—	A	2,154	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series A-1 Preferred Stock^F1	—	Jul 7, 2015	C	251	D	—	—	Common Stock	1,315	D
Series C-1 Preferred Stock^F2	—	Jul 7, 2015	C	1,657	D	—	—	Common Stock	725	D
Series F Preferred Stock^F3	—	Jul 7, 2015	C	4,923	D	—	—	Common Stock	2,154	D

F1Each share of Series A-1 Preferred Stock automatically converted into Common Stock on a 5.2391-for-one basis immediately prior to the closing of the issuer's initial public offering and had no expiration date.
F2Each share of Series C-1 Preferred Stock automatically converted into Common Stock on a 0.4375-for-one basis immediately prior to the closing of the issuer's initial public offering and had no expiration date.
F3Each share of Series F Preferred Stock automatically converted into Common Stock on a 0.4375-for-one basis immediately prior to the closing of the issuer's initial public offering and had no expiration date.